E-Choice option for Elsevier's Science/Direct by Douglas, Kimberly et al.
E-Choice option for Elsevier’s Science/Direct 
Kimberly Douglas,  Dana Roth  
  Caltech Library System 
and 
David Goodman  
Princeton University Library 
 
February 2002 
 
If there’s one thing that seems to be as reliable as the rising sun, it’s that each year brings 
a new ScienceDirect pricing scheme from Elsevier.  This might be seen in the positive 
context of flexibility and a willingness to adapt and/or learn.  With E-Choice Elsevier has 
formally adopted the perspective of those institutions for which quality trumps quantity.  
Elsevier expresses it as “depth [4 yr. backfile] over breadth” [entire online collection].  
Additionally, arguments based on use-data must have resonated so that now the phrase 
“libraries predetermined collection” is a marketing slogan.  Nevertheless selection of E-
Choice, as with all contracts, must be based on a complete and thorough evaluation of the 
proposal and of possible ensuing alternate proposals. To start evaluating this latest offer 
from Elsevier, it’s best to approach it very methodically: 
 
First, re-write the offer1 without the marketing adjectives and modifying clauses.  
Second, define the nouns.  Then evaluate the remaining factual information for 
completeness, compare with the IDEAL/ScienceDirect Integration FAQ 2 (IDEAL/SD 
FAQ) and prepare to negotiate. 
 
The Offer, distilled from http://www.info.sciencedirect.com/index_f76.html.  Minus 
the advertising:   
 
ScienceDirect is launching a license option for academic libraries to gain 
electronic access to both Elsevier Science and Academic Press journals.  E-
Choice enables access via a single platform with a single license agreement.  E-
Choice provides a transition to an electronic collection. 
 
Elsevier Science is integrating the Academic Press journals into Science Direct.  
From January 2002, an E-Choice license will cover access to journals on both 
ScienceDirect and IDEAL platforms.  In May 2002, all IDEAL titles will be 
available on the ScienceDirect platform – providing an interface with full text 
searching supported by Lexis Nexis. 
· Academic Press titles will be available via the ScienceDirect platform. 
· Academic Press titles will be added to the ScienceDirect backfile 
program. 
 
How does E-Choice work? 
Under an E-Choice license, a base price is determined that reflects your current 
subscribed collection.  The E-Choice license fee for electronic access to this 
                                                 
1 The E-Choice offer is described in multiple places: http://www.info.sciencedirect.com/index_f6.html and 
http://www.info.sciencedirect.com/index_f76.html .  The latter explanation posted under “Product Options” 
was determined to be the most formal presentation.  On February 6, 2002 this link 
http://www.info.sciencedirect.com/index_f32.html  became available. 
2 See: http://www.info.sciencedirect.com/index_f71.html for the IDEAL/SD FAQ 
collection is charged at a percentage of the base price.  Print is offered as an 
optional additional format at a price. 
 
Customers familiar with IDEAL will recognize this license approach.  
ScienceDirect decided to add this model to its range of license options. 
· E-Choice licensees gain access to four years of backfiles for titles 
previously held in print. 
· Current ScienceDirect Inter Library Loan and archiving policy apply to 
E-Choice. 
 
 
Specific License Issues: 
  
License approach and options  
Elsevier advertises a single agreement as an improvement and cost-saving.  It is, 
however, the inevitable consequence of a business that ultimately functions as a 
monopoly.3  While change seems a long way off, keep in mind that it would be more 
productive for scholarly research publishing to be operating under a common legal 
understanding that does not require the frequent duplicative renegotiations 
necessitated in the current industry.   
 
Over the years Elsevier has developed at least 4 other options for SD:   
· Web Editions (12 month rolling-window free with the print subscription, for most 
titles) was launched 2 years ago in response to marketplace critique;  
· Classic ScienceDirect (All subscribed titles for a premium over list) has evolved 
over the last 5 years with varying percentages ranging from 7% to 12.5% ; 
Portfolio and selected individual Subject Collections fees (usually additional to 
Classic ScienceDirect) is the latest variation in which Elsevier dropped the 
consortial approach for unifying collections and broadening access in favor of a 
one on one negotiation for electronic access to more titles;  
· Limited Collection is a customized list of electronic versions of at least ten 
subscribed-to titles for a 25% premium over subscription price.   
In addition, an undefined “Freedom Collection” subscription is mentioned in Elsevier 
advertising. Now Elsevier launches E-Choice, essentially a variation on the Classic 
ScienceDirect in which the subscription fees are “flipped” to the electronic to mimic 
the IDEAL model. 
 
There are a number of IDEAL license features singularly lacking from the E-Choice 
approach.   The IDEAL license included access to all the Academic Press titles based 
on the commitment to the base figure and premium.  In the IDEAL/SD FAQ#20 
Elsevier does seem to be saying that that agreement will not be continued.  Clearly 
there will be some difficult negotiations to agree on “equivalent or better value.”  
While no mention is made of penalties for canceling titles from E-Choice, this has 
                                                 
3 Maarten Cornet and Ben Vollard. Tackling the Journal Crisis. CPB Working Paper 121. March 2000. 
http://www.cpb.nl/eng/pub/werkdoc/121/  (CPB Netherlands Bureau for Economic Policy Analysis, The 
Hague, The Netherlands) makes the case regarding the failure of scholarly publishing as a market when 
authors pay publishers with copyright instead of money. 
been the practice in other Elsevier contracts.  Of course, it was not an issue in the 
IDEAL license since access to all the titles was a feature of the license.   If Elsevier 
does not intend to continue the conditions of the IDEAL licenses what is the 
transactional access option for titles not included in the E-Choice contract?  And what 
will it cost?  Further encroachment into customer choice is the requirement to 
consolidate purchases to a single contact or purchasing agent for the print copies as 
explained in the IDEAL/SD FAQ item #21.  Finally, the wording, “Account 
Managers will review these licenses on a case-by-case basis,” IDEAL/SD FAQ#7, 
constitutes a heads-up for an involved process.  Apparently all licenses will be 
customized and it will be up to each client to achieve the best results for their 
institution. 
 
Single platform and interface 
The customer base should have the option of choosing which platform to consolidate 
on and in that way, Elsevier would gain valuable market information as to which 
platform and interface to continue to develop and support.   Additionally, moving 
IDEAL titles to S/D puts the fulltext links from external A&I services such as 
PubMed at risk.  It took Elsevier six months to restore the Cell Press links in Pubmed 
when it was purchased.  This is indicative of the weakness of the commercial sector’s 
involvement in scholarly publishing.  Scholars do not view research articles as 
commodities similar to Pepsi and CocaCola that can be chosen, to the exclusion of 
the other based on individual taste.  Libraries serve the scholars by assuring that there 
are comprehensive tools available for discovery of relevant material regardless of 
publisher and source.  Therefore, to many, the availability and added cost of the 
discrete Elsevier database is not particularly valued except for know-item retrieval.  It 
would be preferred to have the choice of not including that access in the license for a 
reduced charge. 
  
Content  
The wise Elsevier customer always prepares a detailed and specific list of titles to be 
included in the license.  Such a list must also include title changes that are covered in 
the time period being addressed and volumes and years should be stated.  Elsevier 
uses the phrase, “current subscribed collection.”  Does this include faculty personal 
subscriptions?   
 
The backfile program is newly separated from the Classic ScienceDirect license.   
Previously, backruns of journals were added to the subscription access as they 
became available.  Price information recently posted on the web site states that these 
files “will be priced for one-time purchase.”  While the IDEAL/SD FAQ states that 
existing agreements will be upheld, there is also a statement that Elsevier will track 
usage of the AP collection to provide more targeted content in the package.  
Therefore a selection of titles will be made.  Many libraries may wish to continue the 
arrangement they had with IDEAL.  The premium had already been negotiated once 
for the value.  The understanding of most libraries, in purchasing the IDEAL 
backfiles for a one-time fee, is that that purchase was in perpetuity not limited to the 
duration of that license.  It is also not clear how Elsevier will add IDEAL titles to the 
appropriate SD subject collections already purchased.  Will those titles automatically 
roll into the collection and be accessible at no further increase in fees?  Some Elsevier 
titles have a longer backfile than 4-5 years, is access suddenly being cut off to those 
SD subscribers? 
 
 
 
 
Pricing 
Pricing remains the great hidden issue with Elsevier.  No specific details are publicly 
posted regarding the criteria for establishing the base price figure.  Is the base price 
yet another schedule in addition to the YEN, USA and EUR 
http://www.elsevier.nl/homepage/subpricelist/  pricelists?    Is it based on a specific year, if 
so, which year? A “reduced percentage” only adds to the perplexity.  Nor is it 
established what percentages are involved in the print cost in E-Choice.  Given that 
the cost of the IDEAL package for each library has been decoupled from the 
historical print subscription list, how are the IDEAL fees going to be included in 
setting this base price?  Will there be additional fees, such as platform, portfolio or 
other, included in the base price, as has been the case in other types of Elsevier 
licenses. 
 
 
An Ownership Reality: 
 
Little does Elsevier seem to realize that the very action of purchasing another publisher’s 
line, an activity with little or no retrospective impact in the print world, vividly illustrates 
the underlying vulnerability of the online environment for the scholarly community.  
Research organizations must now re-evaluate the re-packaging, conduct a re- licensing 
exercise with no guarantee of either’s permanence.  There are no conventions, no laws 
that ensure the scholarly community that the materials cannot be removed from their 
access.   
· How will Elsevier warrant that it owns the content in E-Choice or at least owns 
the right to sell libraries irrevocable access and is, in fact, selling us such access?   
· How will Elsevier guarantee that all the content will remain permanent ly 
available, and that Elsevier will not:  
o sell to any third party any rights in such a way that it becomes unavailable 
to customers without additional cost? 
o permit any third party, including even the society that sponsors the 
journal, to withdraw material once published?  
Without some legally binding permanent guarantee, of which contract law’s capacity is 
highly questionable, the transition to all-electronic journals is not truly reliable. 
 
 
Three Financial Realities:  
 
Base price  
The base figure from which all percentage calculations are derived is the critical budget 
containment tool.  One percent of 100,000 will always be more than 50% of 1,000.  A 
low percentage increase constitutes a marketing smoke screen when applied to 
historically inflated base figures. 
  
Exchange rate  
Elsevier does not clearly state its methodology for applying an exchange rate for 
calculating US$ subscription costs from their EURO based costs in the Netherlands.  
EURO prices were established for 2002 subscriptions on September 1, 2001. For 
Biochimica Biophysica Acta the EURO subscription price is 11,545 EURO 
http://www.elsevier.com/homepage/subpricelist/ 
The interbank exchange rate on 9/1/01 for EURO to US$ was $0.91 (i.e. each EURO 
should cost 91 cents) http://www.oanda.com/convert/fxhistory  
 
The posted Elsevier US$ 2002 subscription prices for Biochimica et Biophysica Acta 
($12,915)  calculates out to an Elsevier exchange rate of  $1.12 (i.e. each Elsevier EURO 
costs $1.12).  If Elsevier had used the September 1 exchange rate ($0.91) for BBA, the 
US$ subscription price would have been $10,506.  The difference ($12,915 - $10,506 = 
$2,409) is a 23% exchange rate profit for Elsevier.  This figure is reflected across entire 
collection. 
 
Rule of 70  
Also remember the Rule of 70.  It provides an easy way to calculate the approximate 
number of years it takes for a variable growing at a constant rate to double.  The formula: 
The approximate number of years n for a variable growing at the constant growth rate of 
R percent, to double is  n= 70/R.   An annual cost increase of 6.5% will double the base 
in 10.76 years.  At 10%, it is 7 years; at 12% it is 5.83 years.   
 
 
Conclusion 
 
The E-Choice option stands far too short on details to perform a complete analysis.  As 
an option it is distinctly lacking in the specifics that one would expect to see by now, or 
better, to have seen by last June, in order to have a completed and implemented the 
agreement by January 2002.   In its time IDEAL offered an original approach to 
electronic access licensing.  Elsevier’s SD reflected another.  Each presumed different 
market needs and values.  Elsevier might have been better advised to allow a choice of 
“breadth over depth” instead of dictating their “better value.” The E-Choice license 
option continues in the Elsevier mode of requiring a high investment of time and effort to 
clarify even the obvious details.  Leave no question unanswered; no detail unspecified.  
Finally, gird your loins, and prepare to negotiate.   
 
 
